Ligand based Drug Design of New Heterocyclic Imines of GABA Analogues: A Molecular Docking Approach for the Discovery of New GABA-AT Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-6166|17|1|58-63

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.17, Iss.1, 2017-02, pp. : 58-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fragment-Based Drug Discovery and Molecular Docking in Drug Design

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 1, 2015-01 ,pp. : 11-25

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery

By  

Current Computer - Aided Drug Design, Vol. 7, Iss. 2, 2011-06 ,pp. : 146-157

Bentham Science Publishers

Access to resources Recommend Favorite

Anticonvulsive activity of a new GABA mimetic drug

By Capasso A.   Biondi A.   Palagiano F.   Bonina F.P.   Montenegro L.   de Caprariis P.   Pistorio E.   Sorrentino L.  

European Neuropsychopharmacology, Vol. 7, Iss. 1, 1997-02 ,pp. : 57-63

Elsevier

Access to resources Recommend Favorite

Role of Ligand-Based Drug Design Methodologies toward the Discovery of New Anti- Alzheimer Agents: Futures Perspectives in Fragment-Based Ligand Design

By  

Current Medicinal Chemistry, Vol. 19, Iss. 11, 2012-04 ,pp. : 1635-1645

Bentham Science Publishers

Access to resources Recommend Favorite

Alpidem analogues containing a GABA or glycine moiety as new anticonvulsant agents

By Trapani G.   Latrofa A.   Franco M.   Carrieri A.   Cellamare S.   Serra M.   Sanna E.   Biggio G.   Liso G.  

European Journal of Pharmaceutical Sciences, Vol. 18, Iss. 3, 2003-03 ,pp. : 231-240

Elsevier

Access to resources Recommend Favorite